Rising Demand For Tissue Engineering And Organ Transplantation Will Boost The Organoids And Spheroids Market, Forecast To Touch US$ 1.8 Bn By 2027 At A CAGR Of 19.8% iCrowd Newswire The organoids and spheroids market are growing at a steady pace on account of the innovation in the tissue culture system and frequent failures in organ transplantation surgeries, and the technological developments in the 3D spheroid technology. The growth of the organoids and spheroids market is further driven by the surging demand for organoid-based research models in the developed regions and the increased application of organoid culture in drug discovery. Both organoid and spheroid technology has been extensively used in personalized medicine, disease modeling, and optimizing drug discovery and regenerative medicine. Mainly, the application of organoids is gaining considerable momentum in CRISPR research that could potentially help scientists and researchers better interpret organ development from the perspective of gene editing.